Consideration of the uses and risks of co-trimoxazole from the therapeutic point of view H. Lode OriginalPaper Pages: S231 - S231
Microbiological perspectives of Co-trimoxazole A. BauernfeindG. HörlB. Przyklenk OriginalPaper Pages: S232 - S235
Risk-benefit analyses of drugs: Fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole N. VictorJ. Hasford OriginalPaper Pages: S236 - S240
Clinical and practitioners' reports on adverse effects of co-trimoxazole E. WeberT. JacubeitI. Walter-Sack OriginalPaper Pages: S241 - S247
Hematological side effects of co-trimoxazole H. HeimpelA. Raghavachar OriginalPaper Pages: S248 - S253
Co-trimoxazole-induced hepatic injury — an analysis of cases with hypersensitivity-like reactions P. A. BergP. T. Daniel OriginalPaper Pages: S259 - S264